If pancreatic cancer had a “level” system like a video game, staging would be the part where the game tells you
where you are on the map, which areas the “boss” has reached, and what gear you’ll need next.
In real life, staging helps your care team describe how far the cancer has grown or spread, estimate what treatment
options make the most sense, and choose the best order to do them in.

This article focuses on the most common typepancreatic ductal adenocarcinoma (often shortened to pancreatic
“adenocarcinoma” or “exocrine” pancreatic cancer). Neuroendocrine tumors (pNETs) can be staged differently and often
behave differently, so we’ll briefly flag that later.

Quick note: This is educational information, not personal medical advice. Staging can be complex, and your exact stage depends on imaging, biopsy/pathology, and sometimes surgery.

Why Staging Matters (More Than Just a Number)

Pancreatic cancer staging answers three big questions:

• How big is the main tumor? (Size and local growth)
• Has it reached nearby lymph nodes?
• Has it spread to distant organs? (Most often the liver, peritoneum, or lungs)

Just as important, pancreatic cancer is often discussed in a second, very practical way:
Can a surgeon remove it completely? That “surgery question” is where the term
resectability comes in.

Two Ways Doctors Talk About Stage

1) Numbered stages (Stage 0 to Stage IV)

This is the familiar “Stage 1, 2, 3, 4” approach. In general, lower stages mean the cancer is more contained,
while higher stages mean it has spread further.

2) Resectability groups (resectable vs borderline vs locally advanced vs metastatic)

In pancreatic cancer, these categories can drive treatment decisions as much as the number stage:

• Resectable: Imaging suggests the tumor can be removed completely with surgery.
• Borderline resectable: The tumor is close to (or involves a small part of) key blood vessels, so surgery may be possibleoften after chemotherapy (and sometimes radiation) to improve the odds of a clean removal.
• Locally advanced (unresectable): The tumor involves major arteries or vessels in a way that makes complete surgical removal unlikely at diagnosis, but it hasn’t spread to distant organs.
• Metastatic: The cancer has spread to distant sites.

Important nuance: the exact definition of “borderline resectable” can vary between guidelines and
cancer centers because it depends on which vessel is involved and how much contact the tumor has with it. This is
one reason second opinions at high-volume pancreatic centers can be especially helpful.

The TNM System (The “Recipe Card” Behind the Stage)

Many pancreatic cancer stages are assigned using the TNM system:

• T (Tumor): how large the primary tumor is and whether it involves major arteries.
• N (Nodes): whether cancer is found in nearby lymph nodes.
• M (Metastasis): whether it has spread to distant organs.

In the commonly used AJCC 8th edition framework (often referenced in U.S. oncology care), the “T” category for
pancreatic cancer is heavily size-based, with a special category for major artery involvement:

• T1: tumor ≤ 2 cm (and can be subdivided into very small size ranges)
• T2: > 2 cm and ≤ 4 cm
• T3: > 4 cm
• T4: tumor involves major arteries (such as the celiac axis, superior mesenteric artery, and/or common hepatic artery), regardless of size

For lymph nodes:

• N0: no involved regional lymph nodes
• N1: 1–3 involved regional lymph nodes
• N2: 4 or more involved regional lymph nodes

And for metastasis:

• M0: no distant metastasis found
• M1: distant metastasis present

Pancreatic Cancer Stages at a Glance

That table is the “zoomed out” view. Next, let’s get specific.

Stage 0 (Carcinoma in Situ): The “Caught Before It Broke the Fence” Stage

Stage 0 means abnormal cells are limited to the lining of pancreatic ducts and have not invaded deeper tissues.
In AJCC-style terms, this is often labeled Tis, N0, M0. It can include high-grade precancerous or
noninvasive lesions (your team may use terms like PanIN-3 or high-grade dysplasia in certain cystic lesions).

Reality check: Stage 0 is rarely found because the pancreas is tucked deep in the abdomen and early
changes often cause no symptoms.

Stage I: Small, Localized, and (Sometimes) Operable

Stage IA

Stage IA generally means a tumor 2 cm or smaller and still confined to the pancreas,
with no lymph node involvement and no distant spread.

Stage IB

Stage IB usually means the tumor is larger than 2 cm but not larger than 4 cm, still
without lymph node involvement or distant spread.

Typical treatment pattern: If imaging suggests the tumor is resectable, surgery is often the cornerstone.
The most common operation for tumors in the head of the pancreas is the Whipple procedure
(pancreaticoduodenectomy). Tumors in the body or tail may be treated with a distal pancreatectomy.
Chemotherapy is commonly recommended either after surgery (adjuvant) or before surgery (neoadjuvant) depending on the
case and center practices.

Think of Stage I as “local,” but not necessarily “easy.” Even small pancreatic tumors can behave aggressively,
which is why systemic therapy is usually part of the plan.

Stage II: Bigger Tumor and/or Nearby Lymph Nodes (Still No Distant Spread)

Stage IIA

In the AJCC-style grouping, Stage IIA often corresponds to a tumor larger than 4 cm
with no regional lymph node involvement and no distant metastasis.

Stage IIB

Stage IIB is typically defined by involvement of 1–3 nearby lymph nodes (N1),
with no distant spread. The tumor size can vary (it may be smaller or larger), but the lymph nodes bump the stage.

Typical treatment pattern: If the tumor is clearly resectable, many patients receive surgery plus
chemotherapy (often with careful attention to recovery, nutrition, and supportive care). If the tumor is
borderline resectable, the plan often starts with chemotherapy (and sometimes radiation) to improve the
odds that surgery can remove the tumor completely with clear margins.

A helpful mental model: Stage II is where the “number stage” may still sound “not too high,” but the
resectability label starts to matter a lot. Two people can both be “Stage II” while one is
straightforwardly resectable and the other is borderline because of vessel involvement.

Stage III: Locally Advanced or Heavier Lymph Node Burden

Stage III generally describes cancer that is still non-metastatic (no distant spread),
but is more advanced locally. In AJCC-style terms, Stage III can include either:

• N2 disease: cancer in 4 or more regional lymph nodes, and/or
• T4 disease: tumor involvement of major arteries (which often makes immediate surgery difficult)

Typical treatment pattern: Many Stage III cases are considered locally advanced at
diagnosis, meaning surgery is not usually the first move. Treatment often starts with systemic therapy.
Depending on response and anatomy, some patients may be considered for radiation, and a smaller subset may become
surgical candidates latersometimes called “conversion to resectable,” though it’s not guaranteed.

This is also a stage where you may hear a lot about “multidisciplinary care”surgeons, medical oncologists,
radiation oncologists, gastroenterologists, radiologists, nutrition specialists, and palliative care/supportive care
teams all bringing their superpowers to the same table.

Stage IV: Metastatic Pancreatic Cancer

Stage IV means the cancer has spread to distant organs or sites (that’s M1).
This is most commonly the liver or the lining of the abdomen (peritoneum), but other sites are possible.

Typical treatment pattern: Treatment usually focuses on systemic therapy (chemotherapy and/or
targeted therapy, depending on tumor biomarkers) and symptom relief. Palliative/supportive care can be started at
any stage and is especially valuable in Stage IV to manage symptoms, maintain strength, and support quality of life.
Clinical trials may be an option across stages, and they can be especially important in metastatic disease.

How Doctors Figure Out the Stage

Staging is a process, not a single test. Common tools include:

Imaging

• Pancreas-protocol CT scan to look at the tumor, nearby vessels, lymph nodes, and liver.
• MRI (sometimes MRCP) when more detail is needed or CT isn’t ideal.
• Endoscopic ultrasound (EUS) for close-up imaging and to guide biopsy in many cases.

Biopsy and pathology

A biopsy can confirm cancer type and may enable molecular testing. Sometimes the final stage becomes clearer
after surgery, when pathologists can examine the tumor and lymph nodes directly.

Blood tests (including CA 19-9)

CA 19-9 is commonly used as a tumor marker in pancreatic cancer careespecially to help monitor response to
treatment in patients who produce it. But it’s not a perfect “yes/no” test. It can be elevated for reasons other
than cancer (like bile duct obstruction), and some people don’t produce CA 19-9 at all due to their biology.

Staging laparoscopy (in selected cases)

In certain situationsespecially when imaging suggests potentially resectable disease but there’s concern for tiny
metastasessome teams may recommend a minimally invasive look inside the abdomen before proceeding to major surgery.

Clinical Stage vs Pathologic Stage: Why Your Stage Might “Change”

You may hear:

• Clinical stage (cTNM): estimated based on scans, biopsies, and exams before any surgery.
• Pathologic stage (pTNM): assigned after surgery, using what the pathologist finds in the removed tissue.

Because imaging can’t always detect microscopic lymph node involvement (or tiny metastases), the pathologic stage
can be more precise. This is one reason stage estimates can shift after surgeryyour doctors aren’t moving the
goalposts; they’re getting better information.

Where “Resectable” Fits In (And Why It’s Not Always the Same as Stage I or II)

It’s tempting to assume:

“Stage I or II = surgery, Stage III or IV = no surgery.”

Real life is messier. Resectability depends on anatomyespecially how the tumor relates to major blood vessels.
A tumor can be relatively small but still borderline resectable if it involves key vessels.
Conversely, some Stage III situations might become operable after a strong response to systemic therapy, depending on
the center and individual factors.

Here’s a plain-language way to think about it:

• Resectable: the surgeon expects they can remove it completely without “leaving tumor behind” at the edges.
• Borderline resectable: removal might be possible, but it’s risky for margins or vessel safetyso treatment often starts with chemo to improve the odds.
• Locally advanced: the tumor is wrapped up in major arteries or vessels enough that complete removal isn’t realistic at diagnosis.

Prognosis and Survival: The Honest (but Not Hopeless) Conversation

Stage matters because, broadly speaking, cancers that are localized to the pancreas are more likely to be
resectable and have better outcomes than cancers that are metastatic.

Population statistics often use SEER summary stageslocalized, regional, and
distantwhich don’t map perfectly onto Stage I–IV but are helpful for big-picture understanding.
In the U.S., 5-year relative survival is much higher for localized disease than for distant metastatic disease.

Still, your individual outlook depends on many factors besides stage: overall health, tumor biology, response to
therapy, surgical margins (if surgery happens), lymph node findings, and whether actionable biomarkers are present.
That’s why you’ll often see your care team treating the stage as the starting pointnot the whole story.

Special Case: Pancreatic Neuroendocrine Tumors (pNETs)

Not all pancreatic cancers behave the same. Pancreatic neuroendocrine tumors can have different grading and staging
approaches and often different outcomes and treatments compared with pancreatic ductal adenocarcinoma.
If your diagnosis includes “neuroendocrine,” “NET,” or “pNET,” make sure staging and treatment are discussed in that
specific context.

Questions to Ask Your Care Team About Staging

• What is my TNM stage and what does each letter/number mean in my case?
• Is my cancer considered resectable, borderline resectable, locally advanced, or metastatic?
• Which scans were used to stage it, and do we need additional imaging (or repeat imaging) before deciding next steps?
• Do you recommend biomarker or genetic testing of the tumor (and/or inherited genetic testing)?
• Would a second opinion at a high-volume pancreatic cancer center change anything about staging or treatment sequencing?
• What symptoms should I report right away, and what supportive care options can help during treatment?

Real-World Experiences With Staging (About )

Staging sounds like a clinical label, but for many people it feels like a cliffhanger episodeexcept the season
finale is scheduled by radiology.

A common first experience is the “scan vocabulary crash course.” Suddenly you’re hearing terms like
“pancreas-protocol CT,” “EUS,” “nodes,” “lesion,” “encasement,” and “mets.” People often describe Googling those words
at 2 a.m. like it’s their second jobonly to discover that the internet is full of both great education and
completely unhelpful doom-scrolling. Many patients find it steadier to keep a running list of questions for their
actual care team (and to bring a friend or family member to appointments to take notes).

Another very real experience: the emotional whiplash between number stage and resectability.
Someone might hear “Stage II” and feel a flicker of reliefthen hear “borderline resectable” and think,
“Wait… is that good or bad?” Others hear “Stage III” and assume surgery is off the table forever, when the truth can
be more nuanced. Many cancer centers now talk about staging in a two-part way“Here’s the TNM stage, and here’s what
it means for surgery”because that’s how people actually make sense of it.

People also talk about the waitingwaiting for scan appointments, waiting for pathology, waiting for
a tumor board discussion, waiting to see whether chemo shrinks the tumor enough to change the plan. Some describe
staging as being stuck at a traffic light that won’t turn green until every specialist has walked past the car and
nodded thoughtfully. While that can be frustrating, it’s also a sign that pancreatic cancer decisions are often best
made with a multidisciplinary team and careful imaging review.

Caregivers often describe their own side quest: learning how to support someone through staging without turning
every conversation into a medical meeting. A practical tip that comes up again and again is setting aside
“cancer-planning time” and also protecting “normal-life time”even if normal is just watching a show together and
agreeing that for 45 minutes, nobody is allowed to say the words “lymph node.”

Finally, many people mention that staging appointments are when they first hear about supportive care:
nutrition help (because the pancreas is a digestion MVP), symptom management, pain control options, and emotional
support. The experience of staging isn’t just about labeling the cancerit’s about building a plan that’s both
medically sound and realistically livable.

Conclusion

Pancreatic cancer staging can feel like alphabet soup (TNM) mixed with a number line (0–IV) and topped with a very
important question: Can we remove it completely? Understanding the basicshow stages are defined, what
resectable vs borderline vs locally advanced means, and how imaging and pathology shape the final answercan help
you ask sharper questions and feel less blindsided by the process. And while stage is a major factor in treatment
planning, it’s not the whole story. Tumor biology, treatment response, and expert multidisciplinary care all matter,
too.

The post Pancreatic Cancer Stages appeared first on Global Travel Notes.